Category Archives: The Lancet

Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies


Image via Wikipedia The Lancet Oncology, Early Online Publication, 13 September 2011 doi:10.1016/S1470-2045(11)70223-6Cite or Link Using DOI Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies Dr Xavier Castellsagué MD a d , Mireia Díaz MSc a, Salvatore … Continue reading

Posted in Cancer, Cervical cancer, Doctor of Philosophy, Epidemiology, Human papillomavirus, Intrauterine device, Nubia, The Lancet | Leave a comment

Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial


Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trialMs Heather Powell MMedSc,Vanessa E Murphy PhD,Prof D Robin Taylor MD,Prof Michael J Hensley PhD,Kirsten McCaffery PhD,Warwick Giles PhD,Vicki L Clifton PhD,Prof … Continue reading

Posted in asthma, pregnancy, The Lancet | Leave a comment

Vaccine production, distribution, access, and uptake


Image via Wikipedia The Lancet, Volume 378, Issue 9789, Pages 428 – 438, 30 July 2011 Published Online: 09 June 2011 doi:10.1016/S0140-6736(11)60478-9Cite or Link Using DO Vaccine production, distribution, access, and uptake Jon Smith PhD a, Prof Marc Lipsitch DPhil b, Prof Jeffrey W Almond PhD a  Summary For human vaccines … Continue reading

Posted in production methods, public health services, The Lancet, vaccine | Leave a comment

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial


                          Image via WikipediaGriffin SJ, Borch-Johnsen K, Davies MJ, et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening … Continue reading

Posted in ADDITION-Europe, article, cardiovscular risk, Conditions and Diseases, Diabetes mellitus type 2, Endocrine Disorders, GlaxoSmithKline, Health, Novo Nordisk, Pancreas, Primary care, The Lancet | Leave a comment

Prevencion


Dos excelentes articulos de Juan Gervas y Barbara Starfield sobre prevencion. Sin duda y como es de esperar, polemicos como siempre. Espero los disfruten: Two amazing papers by Juan Gervas (Spain) and Barbara Starfield (USA) about prevention. Without doubt, as … Continue reading

Posted in Prevencion, Articulos de interés, Juan Gervas, The Lancet, Barbara Starfield, JECH | Leave a comment

Prevencion


Dos excelentes articulos de Juan Gervas y Barbara Starfield sobre prevencion. Sin duda y como es de esperar, polemicos como siempre. Espero los disfruten: Two amazing papers by Juan Gervas (Spain) and Barbara Starfield (USA) about prevention. Without doubt, as … Continue reading

Posted in Prevencion, Articulos de interés, Juan Gervas, The Lancet, Barbara Starfield, JECH | Leave a comment

Telmisartan: estudio Trascend


Publicado en Lancet: Estudio Trascend – 5926 pacientes, 2954 recibieron 80 mgr de Telmisartan, 2972 placebo. Estudio aleatorizado, controlado. – Analisis por intencion de tratar. Seguimiento entre 51 a 64 meses. – Disminucion de la TA media: HR 0,92 (IC … Continue reading

Posted in Cardiologia, comentario, hipertension arterial, telmisartan, The Lancet, TRASCEND | Leave a comment

Telmisartan: estudio Trascend


Publicado en Lancet: Estudio Trascend – 5926 pacientes, 2954 recibieron 80 mgr de Telmisartan, 2972 placebo. Estudio aleatorizado, controlado. – Analisis por intencion de tratar. Seguimiento entre 51 a 64 meses. – Disminucion de la TA media: HR 0,92 (IC … Continue reading

Posted in Cardiologia, comentario, hipertension arterial, telmisartan, The Lancet, TRASCEND | Leave a comment

Fiebre, paracetamol y riesgo de asma, rinoconjuntivitis y eczema


Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6–7 years: analysis from Phase Three of the ISAAC programme Prof Richard Beasley DSc a , Tadd Clayton MSc b, Prof Julian … Continue reading

Posted in Asma, eczema, Efectos Adversos, paracetamol, rinoconjuntivitis, The Lancet | Leave a comment

Fiebre, paracetamol y riesgo de asma, rinoconjuntivitis y eczema


Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6–7 years: analysis from Phase Three of the ISAAC programme Prof Richard Beasley DSc a , Tadd Clayton MSc b, Prof Julian … Continue reading

Posted in Asma, eczema, Efectos Adversos, paracetamol, rinoconjuntivitis, The Lancet | Leave a comment

The Lancet: Articulos de interes


Safety of drug-eluting stents: demystifying network meta-analysis Given concerns about the safety of drug-eluting stents, Christoph Stettler and colleagues (Sept 15, p 937) provide the most extensive meta-analysis to date comparing sirolimus-eluting stents, paclitaxel-eluting stents, and bare-metal stents: 38 trials … Continue reading

Posted in Articulos de interés, The Lancet | Tagged , , , , , , , | Leave a comment

Actualizacion: Articulos de interes – The Lancet


Clinical update: treating osteoarthritis Osteoarthritis is the most common joint disease, and a leading cause of pain and physical disability in older people. It is also associated with a major disease burden in middle-aged people, and represents 4–5% of disability-adjusted … Continue reading

Posted in Articulos de interés, The Lancet | Tagged , , , | Leave a comment

The Lancet. Vol. 370. Núm. 76329


OriginalesQUASAR Collaborative Group. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Págs. 2020-2029 R TC (s) PDF (s) Comentario Cunningham D, Starling N. Adjuvant chemotherapy of colorectal cancer. Págs. 1980-1981 TC (s) PDF (s) Heneghan C, Perera R. Prevention of hepatitis C in Japan: a lesson … Continue reading

Posted in Articulos de interés, The Lancet | Tagged , , , , , , , , | Leave a comment